← Research LibraryThe BriefFY2025 40-F · headline figures audited against SEC data
Nutrien, the largest global agriculture retailer and the leading potash producer, lifted net income to $2.27B from $0.67B on revenue up 3.5% to $26.89B, while it shut its Trinidad nitrogen plant and put Phosphate under strategic review
The read at a glance✓ Audited against SEC data
- Growth — Revenue up 3.5% to $26.89B, still below the FY2022 peak of $37.88BNote
- Profitability — Operating margin up 675 bps to 13.9%; net income $2.27BOK
- Cash flow — Free cash flow up 40.7% to $2.13B as capex fell 7.1%OK
- Balance sheet — Total equity up 3.8% to $25.32B; debt figures not shownNote
- Accounting quality — KPMG audit; no change in internal control reported; scores not availableNote
- Retail weight — Retail went from 69% to 66% of consolidated salesNote
Business
Nutrien sells crop inputs and services across the farm value chain. Upstream, it mines potash at six Saskatchewan mines and makes nitrogen and phosphate fertilizers in Canada and the US; downstream, its Retail segment sells crop nutrients, crop protection, seed and services to farmers through over 1,800 locations in North America, Australia and South America. Retail went from 69% to 66% of consolidated sales in 2025.
Latest filings
- 6-K · Company announcement (foreign filer)2026-10-05
- 6-K · Company announcement (foreign filer)2026-08-06
- 6-K · Company announcement (foreign filer)2026-08-05
- 6-K · Company announcement (foreign filer)2026-07-14
- 6-K · Company announcement (foreign filer)2026-06-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Nutrien Ltd., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.